Thymalfasin (thymosin alpha-1)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Thymalfasin (thymosin alpha-1), covering 2024-08-27 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]